-
Development and characterisation of [18F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-19 Jing Wang, Xinxin Hu, Yueqi Wang, Rong A, Xiaoqian Li, Ying Sun, Zhengqi Guan, Xiaona Li, Yongyi Wu, Jiannan Wang, Fangyu Zhao, Yang Liu, Hongbin Wang, Hong Yu, Tianyi Wang, Mengyuan Zhu, Xinyu Li, Duoyi Zhang, Wei Chen, Zhaoguo Han, Xilin Sun
-
Quantitative aortic Na[18F]F positron emission tomography computed tomography as a tool to associate vascular calcification with major adverse cardiovascular events Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-19 T. G. F. Lieverse, G. D. van Praagh, D. J. Mulder, H. J. Lambers Heerspink, J. M. Wolterink, R. H. J. A. Slart
-
IPNet: An Interpretable Network with Progressive Loss for Whole-stage Colorectal Disease Diagnosis. IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-19 Junhu Fu,Ke Chen,Qi Dou,Yun Gao,Yiping He,Pinghong Zhou,Shengli Lin,Yuanyuan Wang,Yi Guo
Colorectal cancer plays a dominant role in cancer-related deaths, primarily due to the absence of obvious early-stage symptoms. Whole-stage colorectal disease diagnosis is crucial for assessing lesion evolution and determining treatment plans. However, locality difference and disease progression lead to intra-class disparities and inter-class similarities for colorectal lesion representation. In addition
-
Development of STING probes and visualization of STING in multiple tumor types Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-18 Huanhuan Liu, Jia Liu, Yingxi Chen, Hongzhang Yang, Jianyang Fang, Xinying Zeng, Jingru Zhang, Shilan Peng, Yuanyuan Liang, Rongqiang Zhuang, Gang Liu, Xianzhong Zhang, Zhide Guo
-
Physics-Informed DeepMRI: k-Space Interpolation Meets Heat Diffusion IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-18 Zhuo-Xu Cui, Congcong Liu, Xiaohong Fan, Chentao Cao, Jing Cheng, Qingyong Zhu, Yuanyuan Liu, Sen Jia, Haifeng Wang, Yanjie Zhu, Yihang Zhou, Jianping Zhang, Qiegen Liu, Dong Liang
-
Source Extent Estimation in OPM-MEG: A Two-Stage Champagne Approach IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-17 Wen Li, Fuzhi Cao, Nan An, Wenli Wang, Chunhui Wang, Weinan Xu, Yang Gao, Xiaolin Ning
-
A Multi-Perspective Self-Supervised Generative Adversarial Network for FS to FFPE Stain Transfer IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-16 Yiyang Lin, Yifeng Wang, Zijie Fang, Zexin Li, Xianchao Guan, Danling Jiang, Yongbing Zhang
-
Subjective and Objective Quality Assessment of Colonoscopy Videos IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-16 Guanghui Yue, Lixin Zhang, Jingfeng Du, Tianwei Zhou, Wei Zhou, Weisi Lin
-
M2DC: A Meta-Learning Framework for Generalizable Diagnostic Classification of Major Depressive Disorder IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-16 Jianpo Su, Bo Wang, Zhipeng Fan, Yifan Zhang, Ling-Li Zeng, Hui Shen, Dewen Hu
-
Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-13 Alexandre Lugat, Nicolas Chouin, Florian Chocteau, Mathilde Esnault, Séverine Marionneau-Lambot, Sébastien Gouard, Éric Frampas, Alain Faivre-Chauvet, Mickaël Bourgeois, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, Françoise Kraeber-Bodéré, Catherine Ansquer, Joëlle Gaschet
-
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-13 Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, Marcella Baldewijns, Enrique Havinga, Wies Deckers, Annouschka Laenen, Gaëtan Devos, Alexander Giesen, Steven Joniau, Michel Koole, Wouter Everaerts, Christophe M. Deroose, Karolien Goffin
-
Nuclear Imaging of Bispecific Antibodies on the Rise J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Borna Roohani, Aldred Shane Mendez, Mann Dangarwala, Samantha Katz, Bernadette Marquez-Nostra
Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically approved bsAbs have entered the clinic internationally since 2022. Hence, research on biomedical imaging of various radiolabeled bsAb scaffolds may serve to improve patient selection for bsAb therapy. Here, we provide a comprehensive overview of recent advances in radiolabeled
-
Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Onur Tuncer, Daniel Steinberger, Joseph Steiner, Madeleine Hinojos, Stephanie Y. Rhee, Brad Humphrey, Farhad Jafari, Zuzan Cayci
Our objective is to explore quantitative imaging markers for early prediction of treatment response in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) undergoing [177Lu]Lu-DOTATATE therapy. By doing so, we aim to enable timely switching to more effective therapies in order to prevent time-resource waste and minimize toxicities. Methods: Patients diagnosed with unresectable or
-
Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Rebecca Sullivan, Jinqiang Hou, Lihai Yu, Benjamin Wilk, Jane Sykes, Heather Biernaski, John Butler, Michael Kovacs, Justin Hicks, Jonathan D. Thiessen, Rohan Dharmakumar, Frank S. Prato, Gerald Wisenberg, Leonard G. Luyt, Savita Dhanvantari
The peptide hormone ghrelin is produced in cardiomyocytes and acts through the myocardial growth hormone secretagogue receptor (GHSR) to promote cardiomyocyte survival. Administration of ghrelin may have therapeutic effects on post–myocardial infarction (MI) outcomes. Therefore, there is a need to develop molecular imaging probes that can track the dynamics of GHSR in health and disease to better predict
-
Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Hudson Alakonya, Sofia Koustoulidou, Samantha L. Hopkins, Mathew Veal, Javier Ajenjo, Deborah Sneddon, Gemma Dias, Michael Mosley, Julia Baguña Torres, Francesca Amoroso, Amanda Anderson, Alison H. Banham, Bart Cornelissen
Visual Abstract
-
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Sophie Poty, Laura Ordas, Yana Dekempeneer, Ali Asghar Parach, Laurent Navarro, Francis Santens, Nina Dumauthioz, Manuel Bardiès, Tony Lahoutte, Matthias D’Huyvetter, Jean-Pierre Pouget
Visual Abstract
-
Dual Somatostatin Receptor/18F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Ur Metser, Jose E. Nunez, David Chan, Roshini Kulanthaivelu, Vanessa Murad, Anna T. Santiago, Simron Singh
Our purpose was to prospectively assess the distribution of NETPET scores in well-differentiated (WD) grade 2 and 3 gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and to determine the impact of the NETPET score on clinical management. Methods: This single-arm, institutional ethics review board–approved prospective study included 40 patients with histologically proven WD GEP NETs. 68Ga-DOTATATE
-
Development of 18F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Rick Wray, Audrey Mauguen, Laure Michaud, Doris Leithner, Randy Yeh, Nadeem Riaz, Rosna Mirtcheva, Eric Sherman, Richard Wong, John Humm, Nancy Lee, Heiko Schöder
Tumor hypoxia, an integral biomarker to guide radiotherapy, can be imaged with 18F-fluoromisonidazole (18F-FMISO) hypoxia PET. One major obstacle to its broader application is the lack of standardized interpretation criteria. We sought to develop and validate practical interpretation criteria and a dedicated training protocol for nuclear medicine physicians to interpret 18F-FMISO hypoxia PET. Methods:
-
Preclinical Evaluation of 177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Andrea Galbiati, Matilde Bocci, Domenico Ravazza, Jacqueline Mock, Ettore Gilardoni, Dario Neri, Samuele Cazzamalli
Fibroblast activation protein (FAP) is abundantly expressed in the stroma of most human solid tumors. Clinical-stage radiolabeled FAP ligands are increasingly used as tools for the detection of various cancer lesions. To unleash the full therapeutic potential of FAP-targeting agents, ligands need to remain at the tumor site for several days after administration. We recently described the discovery
-
Diagnostic Accuracy of [18F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Akram Al-Ibraheem, Ahmed Abdlkadir, Ken Herrmann, Jamshed Bomanji, Hossein Jadvar, Hongcheng Shi, Asem Mansour, Diana Paez, Arturo Chiti, Andrew M. Scott
This study evaluates the diagnostic utility of PET/MRI for primary, locoregional, and nodal head and neck squamous cell carcinoma (HNSCC) through systematic review and metaanalysis. Methods: A systematic search was conducted using PubMed and Scopus to identify studies on the diagnostic accuracy of PET/MRI for HNSCC. The search included specific terms and excluded nonhybrid PET/MRI studies, and those
-
[68Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series J Nucl. Med. (IF 9.1) Pub Date : 2024-09-12 Alex J. Poot, Constantin Lapa, Wolfgang A. Weber, Marnix G.E.H. Lam, Matthias Eiber, Alexander Dierks, Ralph A. Bundschuh, Arthur J.A.T. Braat
To date, the imaging and diagnosis of hepatocellular carcinoma (HCC) rely on CT/MRI, which have well-known limitations. Glypican-3 (GPC3) is a cell surface receptor highly expressed by HCC but not by normal or cirrhotic liver tissue. Here we report initial clinical results of GPC3-targeted PET imaging with [68Ga]Ga-DOTA-RYZ-GPC3 (RAYZ-8009), a peptide-based GPC3 ligand in patients with known or suspected
-
Prototype-Guided Graph Reasoning Network for Few-Shot Medical Image Segmentation IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-13 Wendong Huang, Jinwu Hu, Junhao Xiao, Yang Wei, Xiuli Bi, Bin Xiao
-
Diffusion Models for Counterfactual Generation and Anomaly Detection in Brain Images IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-13 Alessandro Fontanella, Grant Mair, Joanna Wardlaw, Emanuele Trucco, Amos Storkey
-
The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-12 Shikuan Guo, Jing Ren, Qingze Meng, Boyuan Zhang, Jianhua Jiao, Donghui Han, Peng Wu, Shuaijun Ma, Jing Zhang, Nianzeng Xing, Weijun Qin, Fei Kang, Jingliang Zhang
-
Long axial field-of-view PET imaging of intraarterial 2-[18F]FDG injection Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-12 Korbinian Krieger, Carola Maria Bregenzer, Luis Weissenrieder, Axel Rominger, Thomas Pyka
-
The wings of progress: technological and radiopharmaceutical innovations in nuclear medicine. Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-12 Gaia Ninatti,Cristiano Pini,Alexandra Lazar,Fabrizia Gelardi
-
EANM position paper on challenges and opportunities of full-ring 360° CZT bone imaging: it’s time to let go of planar whole-body bone imaging Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-11 Richard Graham, David Morland, Sarah Cade, Laetitia Imbert, Emmanouil Panagiotidis, Jens Kurth, Frédéric Paycha, Tim Van den Wyngaert
-
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-11 Margarita Kirienko, Fabrizia Gelardi, Francesco Fiz, Matteo Bauckneht, Gaia Ninatti, Cristiano Pini, Alberto Briganti, Massimo Falconi, Wim J. G. Oyen, Winette T. A. van der Graaf, Martina Sollini
-
Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-11 Leyun Pan, Christos Sachpekidis, Jessica Hassel, Petros Christopoulos, Antonia Dimitrakopoulou-Strauss
-
Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-11 Jie Ma, Siqi Zhang, Nianhui Yang, Jingjie Shang, Xin Gao, Jiahui Chen, Huiyi Wei, Yinlong Li, Hui Zeng, Hao Xu, Jinghao Wang, Steven H. Liang, Rui Wang, Kuan Hu, Lu Wang
-
Predictors for Vulnerable Plaque in Functionally Significant Lesions JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Seokhun Yang MD, Doyeon Hwang MD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Jonathon Leipsic MD, Marta Belmonte MD, Jeroen Sonck MD PhD, Bjarne L. Nørgaard MD PhD, Hiromasa Otake MD PhD, Brian Ko MD PhD, Michael Maeng MD PhD, Jesper Møller Jensen MD PhD, Dimitri Buytaert MSc, Daniel Munhoz MD PhD, Daniele Andreini MD PhD, Hirofumi Ohashi MD PhD, Toshiro Shinke MD PhD, Charles A. Taylor PhD, Emanuele
Vulnerable plaque presents prognostic implications in addition to functional significance. The aim of this study was to identify relevant features of vulnerable plaque in functionally significant lesions. In this multicenter, prospective study conducted across 5 countries, including patients who had invasive fractional flow reserve (FFR) ≤0.80, a total of 95 patients with available pullback pressure
-
A robust image segmentation and synthesis pipeline for histopathology Med. Image Anal. (IF 10.7) Pub Date : 2024-09-11 Muhammad Jehanzaib, Yasin Almalioglu, Kutsev Bengisu Ozyoruk, Drew F.K. Williamson, Talha Abdullah, Kayhan Basak, Derya Demir, G. Evren Keles, Kashif Zafar, Mehmet Turan
Significant diagnostic variability between and within observers persists in pathology, despite the fact that digital slide images provide the ability to measure and quantify features much more precisely compared to conventional methods. Automated and accurate segmentation of cancerous cell and tissue regions can streamline the diagnostic process, providing insights into the cancer progression, and
-
Point Cloud Registration in Laparoscopic Liver Surgery Using Keypoint Correspondence Registration Network IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-10 Yirui Zhang, Yanni Zou, Peter X. Liu
-
Prior-knowledge Embedded U-Net based Fully Automatic Vessel Wall Volume Measurement of the Carotid Artery in 3D Ultrasound Image IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-10 Zheng Yue, Jiayao Jiang, Wenguang Hou, Quan Zhou, J. David Spence, Aaron Fenster, Wu Qiu, Mingyue Ding
-
ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-09 Dongsheng Xu, You Zhang, Wei Huang, Xinbing Pan, Shuxian An, Cheng Wang, Gang Huang, Jianjun Liu, Weijun Wei
-
Positive amyloid and tau PET in an early-onset Alzheimer’s disease with a rare PSEN1 (Arg278Gly) mutation Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-09 Liu Yang, Ping Dong, Li Li, Lin Li, Minggang Su
-
Towards Semantically-Consistent Deformable 2D-3D Registration for 3D Craniofacial Structure Estimation from A Single-View Lateral Cephalometric Radiograph IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-09 Yikun Jiang, Yuru Pei, Tianmin Xu, Xiaoru Yuan, Hongbin Zha
-
Full-wave Image Reconstruction in Transcranial Photoacoustic Computed Tomography using a Finite Element Method IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-09 Yilin Luo, Hsuan-Kai Huang, Karteekeya Sastry, Peng Hu, Xin Tong, Joseph Kuo, Yousuf Aborahama, Shuai Na, Umberto Villa, Mark A. Anastasio, Lihong V. Wang
-
A Tracking prior to Localization workflow for Ultrasound Localization Microscopy IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-09 Alexis Leconte, Jonathan Porée, Brice Rauby, Alice Wu, Nin Ghigo, Paul Xing, Stephen LEE, Chloé Bourquin, Gerardo Ramos-Palacios, Abbas F. Sadikot, Jean Provost
-
Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-06 Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, Thomas Ertveldt, Marion Berdal, Surasa Nagachinta, Kirsten De Ridder, Tony Lahoutte, Marleen Keyaerts, Nick Devoogdt, Cleo Goyvaerts, Matthias D’Huyvetter, Karine Breckpot
-
Evaluating the Utility of 18F-FDG PET/CT in Cancer of Unknown Primary J Nucl. Med. (IF 9.1) Pub Date : 2024-09-05 Tharani Sivakumaran, Anthony Cardin, Jason Callahan, Hui-li Wong, Richard W. Tothill, Rodney J. Hicks, Linda R. Mileshkin
Cancer of unknown primary (CUP) represents a heterogeneous group of metastatic tumors for which standardized diagnostic work-up fails to identify the primary site. We aimed to describe the Peter MacCallum Cancer Centre experience with 18F-FDG PET/CT in extracervical CUP with respect to detection of a primary site and its impact on management. A secondary aim was to compare overall survival (OS) in
-
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT J Nucl. Med. (IF 9.1) Pub Date : 2024-09-05 Matteo Bauckneht, Francesca D’Amico, Domenico Albano, Michele Balma, Camilla Cabrini, Francesco Dondi, Tania Di Raimondo, Virginia Liberini, Luca Sofia, Simona Peano, Mattia Riondato, Giuseppe Fornarini, Riccardo Laudicella, Luca Carmisciano, Egesta Lopci, Roberta Zanca, Marcello Rodari, Stefano Raffa, Maria Isabella Donegani, Daniela Dubois, Leonardo Peñuela, Cecilia Marini, Francesco Bertagna, Alberto
Visual Abstract
-
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer J Nucl. Med. (IF 9.1) Pub Date : 2024-09-05 Bertha Eisses, Jasper J.L. van Geel, Adrienne H. Brouwers, Frederike Bensch, Sjoerd G. Elias, Evelien J.M. Kuip, Agnes Jager, Bert van der Vegt, Marjolijn N. Lub-de Hooge, Jasper Emmering, Anne I.J. Arens, Gerben J.C. Zwezerijnen, Daniëlle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Elisabeth G.E. de Vries, Carolina P. Schröder
Understanding which patients with human epidermal growth factor receptor 2 (HER2)–negative or –low metastatic breast cancer (MBC) benefit from HER2-targeted strategies is urgently needed. We assessed the whole-body heterogeneity of HER2 expression on 89Zr-trastuzumab PET (HER2 PET) and the diagnostic performance of HER2 PET in a large series of patients, including HER2-negative and -low MBC. Methods:
-
C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study J Nucl. Med. (IF 9.1) Pub Date : 2024-09-05 Johanna S. Enke, Kathrin Ritzel, Evelyn Asbach, Nic G. Reitsam, Bruno Märkl, Thomas Knösel, Denise Brüdgam, Malte Kircher, Christian H. Pfob, Ralph A. Bundschuh, Andreas Rinscheid, Bernd Nittbaur, Georgine Wienand, Margret Schottelius, Martin Reincke, Constantin Lapa, Alexander Dierks
C-X-C motif chemokine receptor 4 (CXCR4)–directed imaging has gained clinical interest in aiding clinical diagnostics in primary aldosteronism (PA). We retrospectively evaluated the feasibility of CXCR4-directed scintigraphy using the novel CXCR-4 ligand [99mTc]Tc-pentixatec in patients with PA. Methods: Six patients (mean age ± SD, 49 ± 15 y) underwent CXCR4-directed scintigraphy (including planar
-
Low-dose computed tomography perceptual image quality assessment Med. Image Anal. (IF 10.7) Pub Date : 2024-09-06 Wonkyeong Lee, Fabian Wagner, Adrian Galdran, Yongyi Shi, Wenjun Xia, Ge Wang, Xuanqin Mou, Md. Atik Ahamed, Abdullah Al Zubaer Imran, Ji Eun Oh, Kyungsang Kim, Jong Tak Baek, Dongheon Lee, Boohwi Hong, Philip Tempelman, Donghang Lyu, Adrian Kuiper, Lars van Blokland, Maria Baldeon Calisto, Scott Hsieh, Minah Han, Jongduk Baek, Andreas Maier, Adam Wang, Garry Evan Gold, Jang-Hwan Choi
In computed tomography (CT) imaging, optimizing the balance between radiation dose and image quality is crucial due to the potentially harmful effects of radiation on patients. Although subjective assessments by radiologists are considered the gold standard in medical imaging, these evaluations can be time-consuming and costly. Thus, objective methods, such as the peak signal-to-noise ratio and structural
-
Self-navigated 3D diffusion MRI using an optimized CAIPI sampling and structured low-rank reconstruction estimated navigator IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-06 Ziyu Li, Karla L. Miller, Xi Chen, Mark Chiew, Wenchuan Wu
-
Cohort-Individual Cooperative Learning for Multimodal Cancer Survival Analysis IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-06 Huajun Zhou, Fengtao Zhou, Hao Chen
-
Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-05 Shiman Wu, Tingting Xu, Jiahao Gao, Qi Zhang, Yuxin Huang, Zonglin Liu, Xiaozhu Hao, Zhenwei Yao, Xing hao, Pu-Yeh Wu, Yue Wu, Bo Yin, Zhongmin Tang
-
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-05 Marco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, Matteo Bagnalasta, Stefania Mazzaglia, Federica Scalorbi, Giovanni Argiroffi, Margarita Kirienko, Alice Lorenzoni, Gianluca Aliberti, Sara Pusceddu, Calareso Giuseppina, Garanzini Enrico Matteo, Ettore Seregni, Carlo Chiesa
-
PET/CT with [68Ga]Ga-TEoS-DAZA for localization of a traumatic biliary leak Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-05 Martin Freesmeyer, Julia Greiser, Robert Drescher, Utz Settmacher, Oliver Rohland, Felix Dondorf
-
Labeled-to-unlabeled distribution alignment for partially-supervised multi-organ medical image segmentation Med. Image Anal. (IF 10.7) Pub Date : 2024-09-05 Xixi Jiang, Dong Zhang, Xiang Li, Kangyi Liu, Kwang-Ting Cheng, Xin Yang
Partially-supervised multi-organ medical image segmentation aims to develop a unified semantic segmentation model by utilizing multiple partially-labeled datasets, with each dataset providing labels for a single class of organs. However, the limited availability of labeled foreground organs and the absence of supervision to distinguish unlabeled foreground organs from the background pose a significant
-
ATEC23 Challenge: Automated prediction of treatment effectiveness in ovarian cancer using histopathological images Med. Image Anal. (IF 10.7) Pub Date : 2024-09-05 Ching-Wei Wang, Nabila Puspita Firdi, Tzu-Chiao Chu, Mohammad Faiz Iqbal Faiz, Mohammad Zafar Iqbal, Yifan Li, Bo Yang, Mayur Mallya, Ali Bashashati, Fei Li, Haipeng Wang, Mengkang Lu, Yong Xia, Tai-Kuang Chao
Ovarian cancer, predominantly epithelial ovarian cancer (EOC), is a global health concern due to its high mortality rate. Despite the progress made during the last two decades in the surgery and chemotherapy of ovarian cancer, more than 70% of advanced patients are with recurrent cancer and disease. Bevacizumab is a humanized monoclonal antibody, which blocks signaling in cancer, inhibits angiogenesis
-
Refining salvage radiotherapy strategies for pelvic node recurrence in prostate cancer: insights from salvage lymph node dissection. Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-05 Gaetan Devos,Alexander Giesen,Steven Joniau
-
Characterization of a gonadal vein Capillary Hemangioma by [68Ga]FAPI-46 and [18 F]FDG PET and immunohistochemistry: a potential pitfall of FAPI PET signal Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-04 Masatoshi Hotta, Ameen Seyedroudbari, Sarah Dry, Mark Girgis, Jeremie Calais
-
Treatment Strategy of Atrial Functional Mitral Regurgitation: Consideration of the Mechanistic Subtypes. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Nobuyuki Kagiyama
-
Low-dose CT image super-resolution with noise suppression based on prior degradation estimator and self-guidance mechanism IEEE Trans. Med. Imaging (IF 8.9) Pub Date : 2024-09-04 Jianning Chi, Zhiyi Sun, Liuyi Meng, Siqi Wang, Xiaosheng Yu, Xiaolin Wei, Bin Yang
-
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-02 Timo W.M. De Groof, Yoline Lauwers, Tessa De Pauw, Mohit Saxena, Cécile Vincke, Jolien Van Craenenbroeck, Catherine Chapon, Roger Le Grand, Geert Raes, Thibaut Naninck, Jo A. Van Ginderachter, Nick Devoogdt
-
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer Eur. J. Nucl. Med. Mol. Imaging (IF 8.6) Pub Date : 2024-09-03 Giulia Santo, Gianpaolo Di Santo, Anna Sviridenko, Steffen Bayerschmidt, Lukas Wirth, Fabian Scherbauer, Peter Lehmann, Elisabeth von Guggenberg, Clemens Decristoforo, Isabel Heidegger-Pircher, Jasmin Bektic, Irene Virgolini
-
StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions J Nucl. Med. (IF 9.1) Pub Date : 2024-09-01 Maria Agnese Pirozzi, Valeria Gaudieri, Anna Prinster, Mario Magliulo, Alberto Cuocolo, Arturo Brunetti, Bruno Alfano, Mario Quarantelli
An innovative multicompartmental anatomic brain phantom (StepBrain) is described to simulate the in vivo tracer uptake of gray matter, white matter, and striatum, overcoming the limitations of currently available phantoms. Methods: StepBrain was created by exploiting the potential of fused deposition modeling 3-dimensional printing to replicate the real anatomy of the brain compartments, as modeled
-
Total-Body Dynamic Imaging and Kinetic Modeling of [18F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy J Nucl. Med. (IF 9.1) Pub Date : 2024-09-01 Negar Omidvari, Jelena Levi, Yasser G. Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E. Daly, Guobao Wang, Simon R. Cherry
Immunotherapies, especially checkpoint inhibitors such as anti–programmed cell death protein 1 (anti–PD-1) antibodies, have transformed cancer treatment by enhancing the immune system’s capability to target and kill cancer cells. However, predicting immunotherapy response remains challenging. 18F-arabinosyl guanine ([18F]F-AraG) is a molecular imaging tracer targeting activated T cells, which may facilitate